Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characteristics of Spontaneous Regression in Merkel Cell Carcinoma: A Retrospective Analysis of Patient and Tumor Features.

Autor: Gamissans M; Dermatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain., Muntaner-Virgili C; Dermatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain., Penín RM; Pathology Department, Hospital Universitari de Bellvitge, Barcelona, Spain., Marcoval J; Dermatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.

Publikováno v: Clinical and experimental dermatology [Clin Exp Dermatol] 2024 Dec 14. Date of Electronic Publication: 2024 Dec 14.

Changes in the Location of Cutaneous Melanoma Over the Past 30 Years. A Retrospective Observational Study.

Autor: Ferreres JR; Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España., Molinero Caturla J; Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España., Sánchez Sánchez J; Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España., Gamissans M; Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España., Vinyals A; Centre d'Oncologia Molecular, IDIBELL, Barcelona, Spain., Bermejo J; Servicio de Cirugía Plástica, Hospital Universitari de Bellvitge, Barcelona, España., Penín RM; Servicio de Anatomía Patológica, Hospital Universitari de Bellvitge, Barcelona, España., Fabra À; Centre d'Oncologia Molecular, IDIBELL, Barcelona, Spain., Marcoval J; Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España. Electronic address: jmarcoval@bellvitgehospital.cat.

Publikováno v: Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2024 Oct; Vol. 115 (9), pp. 852-857. Date of Electronic Publication: 2024 May 18.

Ichthyosiform Sarcoidosis.

Autor: Marcoval J; Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España. Electronic address: jmarcoval@bellvitgehospital.cat., Moreno-Vílchez C; Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España., Molinero Caturla J; Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España., Penín RM; Servicio de Anatomía Patológica, Hospital Universitari de Bellvitge, Barcelona, España.

Publikováno v: Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2023 Sep; Vol. 114 (8), pp. 735-737. Date of Electronic Publication: 2022 Oct 21.

Response to "The significance of oral epithelial dysplasia in the clinical management of oral potentially malignant disorders".

Autor: Gómez-Armayones S; Department of Dermatology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Dermatology, Hospital Clínic of Barcelona, Barcelona, Spain., Chimenos-Küstner E; Department of Odontostomatology, Odontological University Hospital of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain., Arranz C; Department Oral and Maxillofacial Surgery, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., Tous S; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Marquez S; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Penín RM; Department of Pathology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., Quirós B; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Taberna M; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Program of Molecular Mechanisms and Experimental Therapy in Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Alemany L; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Servitje O; Department of Dermatology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., Mena M; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: International journal of oral and maxillofacial surgery [Int J Oral Maxillofac Surg] 2023 Apr; Vol. 52 (4), pp. 511. Date of Electronic Publication: 2022 Sep 02.